ARTICLE | Finance
Building Tenaya
Why Gladstone spinout Tenaya is a model investment for TCG's third fund
December 14, 2016 12:43 AM UTC
As the only non-angel investor in cardiovascular company Tenaya Therapeutics Inc.’s $50 million series A round, The Column Group is making good on its plans to invest more and syndicate less with its latest fund.
TCG committed $48 million. On Dec. 7, Tenaya closed the first $10 million tranche of the round...
BCIQ Company Profiles